![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
EU WC
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Amidonal
2. Aprindine
3. Fiboran
1. Aprindine Hcl
2. 33237-74-0
3. Aspenon
4. Fibocil
5. Compound 83846
6. Aprinidine Chloride
7. Amidonal
8. Aprindinehcl
9. Aprindine (hydrochloride)
10. Pb5ekt7q2v
11. N-(2,3-dihydro-1h-inden-2-yl)-n',n'-diethyl-n-phenyl-1,3-propanediamine Hydrochloride
12. Nsc-284614
13. Fiboran
14. Ritmusin
15. 33237-74-0 (hcl)
16. Dsstox_cid_26726
17. Dsstox_rid_81856
18. Dsstox_gsid_46726
19. Lilly 83846
20. N'-(2,3-dihydro-1h-inden-2-yl)-n,n-diethyl-n'-phenylpropane-1,3-diamine;hydrochloride
21. Cas-33237-74-0
22. Ccris 5480
23. Ncgc00167576-01
24. Aprindine Hydrochloride [usan:jan]
25. Einecs 251-418-7
26. Unii-pb5ekt7q2v
27. Nsc 284614
28. Ms 5075
29. Ms-5075
30. Aspenon (tn)
31. N-(2,3-dihydro-1h-inden-2-yl)-n',n'-diethyl-n-phenylpropane-1,3-diamine Monohydrochloride
32. 2-indanamine, N-(3-(diethylamino)propyl)-n-phenyl-, Hydrochloride
33. N,n-diethyl-n'-2-indanyl-n'-phenyl-1,3-propanediamine Hydrochloride
34. N,n-diethyl-n'-2-indanyl-n'-phenyl-1,3-propanediamine Monohydrochloride
35. 1,3-propanediamine, N-(2,3-dihydro-1h-inden-2-yl)-n',n'-diethyl-n-phenyl-, Monohydrochloride
36. Compound-83846
37. Mls004712062
38. Schembl122403
39. Chembl2104501
40. Dtxsid5046726
41. Chebi:31229
42. Hy-a0236a
43. Aprindine Hydrochloride [mi]
44. Tox21_112569
45. Tox21_501190
46. Aprindine Hydrochloride [jan]
47. Aprindine Hydrochloride [usan]
48. 1,3-propanediamine, N,n-diethyl-n'-2-indanyl-n'-phenyl-, Monohydrochloride
49. Akos015994694
50. Aprindine Hydrochloride (jp17/usan)
51. Tox21_112569_1
52. Aprindine Hydrochloride [mart.]
53. Ccg-222494
54. Ks-1222
55. Lp01190
56. Aprindine Hydrochloride [who-dd]
57. Ncgc00167576-02
58. Ncgc00261875-01
59. Smr001456520
60. Cs-0133610
61. D01326
62. Aprindine Hydrochloride, >=98% (hplc), Solid
63. J-019105
64. Q27286446
65. N1-(2,3-dihydro-1h-inden-2-yl)-n3,n3-diethyl-n1-phenylpropane-1,3-diamine Hydrochloride
Molecular Weight | 358.9 g/mol |
---|---|
Molecular Formula | C22H31ClN2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 8 |
Exact Mass | 358.2175767 g/mol |
Monoisotopic Mass | 358.2175767 g/mol |
Topological Polar Surface Area | 6.5 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 332 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)